GLP-3 Cost in 2026: Price, Insurance, and Savings Options

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

Cost is the single most-searched question in the GLP-1 landscape, and "cheap GLP-3" usually means one thing: what will this actually run per month, and how do people pay less than the number they see quoted online? The honest answer is that out-of-pocket cost is built from several moving parts — list price, insurance, savings programs, and whether a compounded formulation is on the table. This article breaks each one down for GLP-1 receptor agonists as of April 2026.

What GLP list price actually is

GLP-1 list price varies by brand — typically $800–$1,600 per month at U.S. list price as of April 2026 (the manufacturer published pricing). List price is rarely what an insured patient pays; it is the starting figure before insurance, rebates, manufacturer savings cards, and pharmacy negotiation. What lands at the counter depends on the plan, formulary, prior authorization, and the indication written on the prescription.

How insurance changes the number

Commercial coverage hinges on whether the prescription is written for an FDA-approved indication and on the plan’s formulary and prior-authorization rules. Many commercial plans cover GLP-1 receptor agonists for type 2 diabetes, while coverage for chronic weight management is more variable, is often gated behind BMI-based prior authorization, and is sometimes excluded outright. Medicare does not cover FDA-approved weight-management drugs for weight alone as of April 2026, though some products have cardiovascular-indication coverage. Check directly with your plan.

Savings cards and pharmacy coupons

The manufacturer publishes a savings-card program that can substantially cut monthly out-of-pocket cost for eligible commercially-insured patients — but eligibility typically excludes Medicare, Medicaid, TRICARE, and other government-funded coverage, and cards carry monthly and annual caps that change over time. Verify terms on the manufacturer website at the time of fill. Independent discount platforms such as GoodRx and SingleCare also publish coupon prices that vary by pharmacy.

The compounding shift of 2024–2025

During the FDA-declared shortages of semaglutide and tirzepatide, 503A compounding pharmacies legally produced compounded versions of these molecules. The FDA resolved the semaglutide shortage in late 2024 and the tirzepatide shortage in early 2025, which narrowed the compounding window without eliminating all legitimate compounding-pharmacy activity. Compounded semaglutide and tirzepatide remain available through licensed pathways where clinically justified. These products are not identical to the FDA-approved brand drugs and are priced separately.

Real out-of-pocket scenarios

With commercial insurance that covers the indication and a savings card applied, eligible patients may pay as little as $25 per month, subject to plan terms and caps. With commercial insurance that does not cover the indication, cash cost sits closer to list price minus any coupon. Without insurance, cash-pay approaches list price; compounded alternatives through PlexusDx Weight Management Protocols follow a separate pricing structure published on each product page.

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols — available as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. What sets the PlexusDx approach apart is the upstream genetic context. Before starting any GLP-1 pathway protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — including variants in FTO, GLP1R, and MC4R that shape your baseline GLP-1, appetite-regulation, and energy-balance biology. Knowing that profile alongside the protocol is the test before you invest approach — turning guesswork into an informed conversation with your healthcare provider.

Related reading on PlexusDx: GLP-1 Drugs, GLP-1 Hormone, What Is GLP-1? (overview), What Is GLP-1? (in depth).

Disclaimer: This article is educational. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols — this article covers the pricing factors and genetic context that inform any decision to use them. PlexusDx does not sell, prescribe, or recommend any other therapeutic peptide in the GLP-1 category beyond semaglutide and tirzepatide (including dulaglutide, liraglutide, retatrutide, cagrilintide, and related compounds). The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Start with the biology underneath every decision. Take the Precision Peptide Genetic Test, or explore the protocol directly.

Frequently Asked Questions

How much does GLP-1 cost per month?

GLP-1 list price varies by brand — typically $800–$1,600 per month at U.S. list price as of April 2026 (manufacturer published pricing). Insurance, savings cards, and pharmacy pricing can substantially change what a patient actually pays at the counter, so verify the current price with the pharmacy before you fill.

Does insurance cover GLP-1?

It depends on the plan, formulary, the FDA indication on the prescription, and prior-authorization criteria. Many commercial plans cover GLP-1 receptor agonists for type 2 diabetes, while chronic weight-management coverage is more variable. Medicare does not cover weight-management indications for weight alone as of April 2026.

Are there coupons or savings cards for GLP-1?

The manufacturer publishes a savings-card program for commercially-insured patients who meet eligibility criteria, and independent platforms like GoodRx publish discount prices. Government-insurance patients are typically excluded from manufacturer cards. Check the manufacturer site at the time of fill for current terms and caps.

Are there lower-cost alternatives to GLP-1?

Licensed 503A pharmacies produce compounded semaglutide and tirzepatide at separate price points from the FDA-approved brand products. Compounded formulations are legally and factually different — not identical, not generics. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols with published per-protocol pricing on each product page.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education